These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 29558348

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Serum free light chains, interferon-alpha, and interleukins in systemic lupus erythematosus.
    Jolly M, Francis S, Aggarwal R, Mikolaitis RA, Niewold TB, Chubinskaya S, Block JA, Scanzello C, Sequeira W.
    Lupus; 2014 Aug; 23(9):881-8. PubMed ID: 24786785
    [Abstract] [Full Text] [Related]

  • 3. Serum free light chains as biomarkers for systemic lupus erythematosus disease activity.
    Aggarwal R, Sequeira W, Kokebie R, Mikolaitis RA, Fogg L, Finnegan A, Plaas A, Block JA, Jolly M.
    Arthritis Care Res (Hoboken); 2011 Jun; 63(6):891-8. PubMed ID: 21312346
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4.
    Julkunen H, Ekblom-Kullberg S, Miettinen A.
    Rheumatol Int; 2012 Aug; 32(8):2445-51. PubMed ID: 21706294
    [Abstract] [Full Text] [Related]

  • 6. Determination of serum free light chains as a marker of systemic lupus flare.
    Rodríguez-Cambrón AB, Jiménez-Jiménez J, Blázquez-Cañamero MÁ, Pazos FR, Macía-Villa C, Alcalde-Villar M, Collado-Ramos P, Del Pozo FMC, Álvarez-Andrés E, Cruz-Valenciano A.
    Clin Rheumatol; 2020 Feb; 39(2):449-454. PubMed ID: 31773496
    [Abstract] [Full Text] [Related]

  • 7. β2-microglobulin as a marker of systemic lupus erythematosus activity.
    Żychowska I, Suszek D, Dryglewska M, Majdan M.
    Adv Clin Exp Med; 2018 Mar; 27(3):379-382. PubMed ID: 29533541
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Association of Serum Ferritin Levels with Hematological Manifestations in Systemic Lupus Erythematosus Patients from Western India.
    Pradhan V, Pandit P, Rajadhyaksha A, Patwardhan M, Surve P, Kamble P, Lecerf M, Bayry J, Kaveri S, Ghosh K, Nadkar MY.
    J Assoc Physicians India; 2016 May; 64(5):14-18. PubMed ID: 27735143
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Anti-CII antibody as a novel indicator to assess disease activity in systemic lupus erythematosus.
    He C, Mao T, Feng Y, Song T, Qin C, Yan R, Feng P.
    Lupus; 2015 Nov; 24(13):1370-6. PubMed ID: 26048288
    [Abstract] [Full Text] [Related]

  • 13. Progressive reduction of serum complement levels: a risk factor for relapse in patients with hypocomplementemia in systemic lupus erythematosus.
    Miyawaki Y, Sada K, Asano Y, Hayashi K, Yamamura Y, Hiramatsu S, Ohashi K, Morishita M, Watanabe H, Matsumoto Y, Kawabata T, Wada J.
    Lupus; 2018 Nov; 27(13):2093-2100. PubMed ID: 30309286
    [Abstract] [Full Text] [Related]

  • 14. Association of Blood Concentrations of Complement Split Product iC3b and Serum C3 With Systemic Lupus Erythematosus Disease Activity.
    Kim AHJ, Strand V, Sen DP, Fu Q, Mathis NL, Schmidt MJ, Bruchas RR, Staten NR, Olson PK, Stiening CM, Atkinson JP.
    Arthritis Rheumatol; 2019 Mar; 71(3):420-430. PubMed ID: 30294950
    [Abstract] [Full Text] [Related]

  • 15. The model of circulating immune complexes and interleukin-6 improves the prediction of disease activity in systemic lupus erythematosus.
    Thanadetsuntorn C, Ngamjanyaporn P, Setthaudom C, Hodge K, Saengpiya N, Pisitkun P.
    Sci Rep; 2018 Feb 08; 8(1):2620. PubMed ID: 29422675
    [Abstract] [Full Text] [Related]

  • 16. Correlation of ESR, C3, C4, anti-DNA and lupus activity based on British Isles Lupus Assessment Group Index in patients of rheumatology clinic.
    Nasiri S, Karimifar M, Bonakdar ZS, Salesi M.
    Rheumatol Int; 2010 Nov 08; 30(12):1605-9. PubMed ID: 19809816
    [Abstract] [Full Text] [Related]

  • 17. Serum human epididymis protein 4 is a predictor for developing nephritis in patients with systemic lupus erythematosus: A prospective cohort study.
    Ren Y, Xie J, Lin F, Luo W, Zhang Z, Mao P, Zhong R, Liang Y, Yang Z.
    Int Immunopharmacol; 2018 Jul 08; 60():189-193. PubMed ID: 29747124
    [Abstract] [Full Text] [Related]

  • 18. Correlations between antinucleosome antibodies and anti-double-stranded DNA antibodies, C3, C4, and clinical activity in lupus patients.
    Saisoong S, Eiam-Ong S, Hanvivatvong O.
    Clin Exp Rheumatol; 2006 Jul 08; 24(1):51-8. PubMed ID: 16539819
    [Abstract] [Full Text] [Related]

  • 19. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P, Deliyska B, Fünfstück R, Hein G, Herrmann D, Stein G.
    Clin Rheumatol; 2003 Oct 08; 22(4-5):271-8. PubMed ID: 14576989
    [Abstract] [Full Text] [Related]

  • 20. Free light chains of immunoglobulins in patients with systemic sclerosis: correlations with lung involvement and inflammatory milieu.
    Bosello S, Basile U, De Lorenzis E, Gulli F, Canestrari G, Napodano C, Parisi F, Pocino K, Di Mario C, Tolusso B, Ferraccioli G, Gremese E.
    J Clin Pathol; 2018 Jul 08; 71(7):620-625. PubMed ID: 29447111
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.